54 related articles for article (PubMed ID: 15318026)
1. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.
Theisen FM; Hinney A; Brömel T; Heinzel-Gutenbrunner M; Martin M; Krieg JC; Remschmidt H; Hebebrand J
Psychiatr Genet; 2004 Sep; 14(3):139-42. PubMed ID: 15318026
[TBL] [Abstract][Full Text] [Related]
2. Dietary Fructose and GLUT5 Transporter Activity Contribute to Antipsychotic-Induced Weight Gain.
Palavicino-Maggio CB; Kuzhikandathil EV
Schizophr Bull; 2016 Sep; 42(5):1270-9. PubMed ID: 27056716
[TBL] [Abstract][Full Text] [Related]
3. Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia.
O'Connell KS; Koch E; Lenk HÇ; Akkouh IA; Hindley G; Jaholkowski P; Smith RL; Holen B; Shadrin AA; Frei O; Smeland OB; Steen NE; Dale AM; Molden E; Djurovic S; Andreassen OA
Psychiatry Res; 2023 Jul; 325():115217. PubMed ID: 37146461
[TBL] [Abstract][Full Text] [Related]
4. Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gain.
Franz M; Papiol S; Simon MS; Barton BB; Glockner C; Spellmann I; Riedel M; Heilbronner U; Zill P; Schulze TG; Musil R
J Psychiatr Res; 2024 Jan; 169():184-190. PubMed ID: 38042056
[TBL] [Abstract][Full Text] [Related]
5. Association between the rs6313 polymorphism in the 5-HTR2A gene and the efficacy of antipsychotic drugs.
Wang Y; Tan X; Chen Z; Zhang B; Gao Y; Wang Y
BMC Psychiatry; 2023 Sep; 23(1):682. PubMed ID: 37726709
[TBL] [Abstract][Full Text] [Related]
6. Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review.
Merino D; Fernandez A; Gérard AO; Ben Othman N; Rocher F; Askenazy F; Verstuyft C; Drici MD; Thümmler S
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745668
[TBL] [Abstract][Full Text] [Related]
7. Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside.
Shad MU
Behav Sci (Basel); 2021 Jun; 11(7):. PubMed ID: 34209185
[TBL] [Abstract][Full Text] [Related]
8. Association of the HTR2C-759C/T polymorphism and antipsychotic-induced weight gain: a meta-analysis.
Chen Y; Wang Y; Fang X; Zhang Y; Song L; Zhang C
Gen Psychiatr; 2020; 33(3):e100192. PubMed ID: 32478286
[TBL] [Abstract][Full Text] [Related]
9. Drug-naive patients with schizophrenia have metabolic disorders that are not associated with polymorphisms in the LEP (-2548G/A) and 5-HTR2C (-759C/T) genes.
Chen J; Tan L; Long Z; Wang L; Hu L; Yang D
Int J Clin Exp Pathol; 2018; 11(12):5969-5980. PubMed ID: 31949685
[TBL] [Abstract][Full Text] [Related]
10. Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics.
Lally J; Gaughran F; Timms P; Curran SR
Pharmgenomics Pers Med; 2016; 9():117-129. PubMed ID: 27853387
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
Zhang JP; Lencz T; Zhang RX; Nitta M; Maayan L; John M; Robinson DG; Fleischhacker WW; Kahn RS; Ophoff RA; Kane JM; Malhotra AK; Correll CU
Schizophr Bull; 2016 Nov; 42(6):1418-1437. PubMed ID: 27217270
[TBL] [Abstract][Full Text] [Related]
12. 759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment.
Del Castillo N; Zimmerman M B; Tyler B; Ellingrod VL; Calarge C
Clin Pharmacol Biopharm; 2013 Jun; 2(2):110. PubMed ID: 24772381
[TBL] [Abstract][Full Text] [Related]
13. No Association between Serotonin Receptor 2C-759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients.
Lee HY; Oh CK; Ham BJ; Chang HS; Paik JW; Won ES; Hahn SW; Shim SH; Kwon YJ; Jung HY; Lee MS
Psychiatry Investig; 2013 Jun; 10(2):190-5. PubMed ID: 23798968
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of antipsychotics: recent progress and methodological issues.
Zhang JP; Malhotra AK
Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):183-91. PubMed ID: 23199282
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
Roerig JL; Steffen KJ; Mitchell JE
CNS Drugs; 2011 Dec; 25(12):1035-59. PubMed ID: 22133326
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of response to antipsychotics in patients with schizophrenia.
Arranz MJ; Rivera M; Munro JC
CNS Drugs; 2011 Nov; 25(11):933-69. PubMed ID: 22054119
[TBL] [Abstract][Full Text] [Related]
17. From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.
Wilffert B; Swen J; Mulder H; Touw D; Maitland-Van der Zee AH; Deneer V;
Int J Clin Pharm; 2011 Feb; 33(1):3-9. PubMed ID: 21365387
[TBL] [Abstract][Full Text] [Related]
18. Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene.
Hoekstra PJ; Troost PW; Lahuis BE; Mulder H; Mulder EJ; Franke B; Buitelaar JK; Anderson GM; Scahill L; Minderaa RB
J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):473-7. PubMed ID: 21186965
[TBL] [Abstract][Full Text] [Related]
19. From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.
Wilffert B; Swen J; Mulder H; Touw D; Maitland-Van der Zee AH; Deneer V;
Int J Clin Pharm; 2013 Jun; 35(3):369-75. PubMed ID: 21049305
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
